Mycetia sinensis
Mycetia sinensis · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Mycetia sinensis is a botanical species of significant pharmacological interest due to its diverse biological properties. Recent studies have focused on its potential activities, particularly its roles as an analgesic and an antioxidant. Research indicates that various preparations of the plant are effective in addressing conditions characterized by inflammation. Specifically, scientific investigations utilize ethanoic, ethanol, and ethanol fractioned extracts to isolate these beneficial compounds. Furthermore, the ethyl acetate (EtOAc) fractioned Mycetia sinensis extract has shown promise in targeted therapeutic applications.
- Synonyms
- Adenosacme Longifolia Var. Sinensis · Mycetia Oligodonta · 1 more
- Common names
- Not available
- Family
- Rubiaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Mycetia sinensis is a complex species that has been classified under several different botanical names throughout its history. Taxonomists have previously identified variations of this plant as Adenosacme longifolia var. sinensis. Additionally, the plant is linked to the synonym Mycetia oligodonta in various scientific records. Some botanical studies have also recognized the specific form known as Mycetia sinensis f. angustisepala. Understanding these diverse synonyms is essential for accurate identification and consistent communication within the botanical community.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Mycetia sinensis is a remarkable organism belonging to the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. This specific plant is a distinguished member of the genus Mycetia. It further belongs to the order Gentianales, showcasing its unique evolutionary lineage. Finally, its botanical identity is solidified by its placement within the Rubiaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Rubiaceae |
| Genus | Mycetia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Mycetia sinensis is a versatile plant species with a wide geographical distribution spanning both temperate and tropical regions of Asia. In the temperate zones, it is primarily found throughout various parts of China, including the South-Central and Southeast regions as well as the island of Hainan. Its reach extends into the tropical landscapes of the Indian Subcontinent, where it can be identified in Bangladesh. Additionally, the species thrives within the Indo-China region, specifically across Myanmar. This diverse range highlights the plant's ability to adapt to multiple distinct ecosystems across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Mycetia sinensis is a self-supporting plant that maintains its own structural integrity without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Mycetia sinensis has demonstrated significant medicinal potential through its documented analgesic and antioxidant activities. Research involving in vivo experiments on Swiss albino mice revealed that extracts from this plant produce a notable percentage of writhing inhibition at concentrated doses. Furthermore, the plant exhibits robust antioxidant properties, showing significant inhibition in assessments such as DPPH and free radical scavenging. Computational molecular-docking investigations further support these findings by highlighting the plant's ability to target key enzymes like COX-2 and 15-LOX-2. These combined results suggest that the phytochemicals found in Mycetia sinensis could serve as valuable precursors for future drug development.
Compounds
Conditions
Mycetia sinensis demonstrates significant medicinal potential through its ability to treat Diabetes mellitus (DM) by targeting specific biological markers. The plant extracts also exhibit effective anti-hyperglycemia properties, which help in regulating glucose metabolism. Furthermore, research indicates that Mycetia sinensis is utilized to treat inflammation, particularly through its inhibitory activities against COX-2 and 15-LOX-2 enzymes. Its diverse pharmacological profile also allows it to treat various types of pain, as evidenced by significant analgesic effects in studies. These combined therapeutic relationships highlight the plant's importance in traditional medicine and future drug development.
Preparations
Mycetia sinensis is prepared as ethanoic extract to evaluate its significant analgesic effects through writhing inhibition. The plant is also prepared as ethanol extract and ethyl acetate extract for pharmacological screening against hyperglycemia and metabolic disorders. Researchers utilize Mycetia sinensis prepared as ethanol fractioned extracts to test for significant improvements in oral glucose tolerance and serum levels. Furthermore, the plant is prepared as ethyl acetate (EtOAc) fractioned Mycetia sinensis extract to demonstrate potent anti-nociceptive and antidiabetic activities. These various preparation methods allow for the detailed identification of phytocompounds and their specific inhibitory activities.